STIMATE (NEEDS NO REFRIGERATION) (desmopressin acetate) by Ferring Pharmaceuticals is acetate's primary pharmacodynamic action involves its binding to vasopressin 2 (v2) receptors. First approved in 1994.
Drug data last refreshed 3d ago
STIMATE is a metered nasal spray formulation of desmopressin acetate, a synthetic vasopressin analog approved in 1994 for treating nocturia. The drug works by binding to V2 receptors in the kidney's collecting ducts, increasing water reabsorption and reducing urine production. It is distinguished by a room-temperature stable formulation that requires no refrigeration, improving patient convenience and compliance.
As an LOE-approaching product with moderate competitive pressure (30), the STIMATE brand faces contraction; commercial teams should expect smaller reimbursement and field organizations, with roles shifting toward managed care and patient retention strategies.
acetate's primary pharmacodynamic action involves its binding to vasopressin 2 (V2) receptors. V2 receptors are primarily located in the distal convoluted tubule and collecting ducts of the nephron in the kidneys. These receptors play a crucial role in regulating water reabsorption and urine…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Desmopressin Acetate 0.2 mg Tablets, Fasting
Working on STIMATE offers exposure to portfolio management, global commercialization, and managed-care negotiation within a large, established pharmaceutical organization. However, the LOE-approaching lifecycle limits advancement potential and team growth; career value lies in crisis management, cost optimization, and transition planning skills.
Worked on STIMATE (NEEDS NO REFRIGERATION) at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
88 open roles linked to this drug
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo